ESSA Pharma Inc
EPIX
Detailliertes Diagramm anzeigen
0.201USD
0.0000.00%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
8.93MMarktkapitalisierung
VerlustKGV TTM
Intraday
1m
30m
1h
D
W
M
D
Heute
0.00%
5 Tage
0.00%
1 Monat
0.00%
6 Monate
-89.24%
Seit Jahresbeginn
0.00%
1 Jahr
-88.16%
Detailliertes Diagramm anzeigen
TradingKey Aktien-Score
Kein Aktien-Score verfügbar aufgrund unzureichender Daten.
ESSA Pharma Inc Nachrichten
Bald gibt es mehr Neuigkeiten, bleiben Sie dran...
Finanzindikatoren
EPS
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Gesamteinnahmen
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
ESSA Pharma Inc Informationen
ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, Masofaniten (formerly EPI-7386), is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). Masofaniten is in development in combination with antiandrogen treatments in patients with prostate cancer who are earlier in their course of the disease. The Company is completing the clinical development of masofaniten as a monotherapy treatment for patients with metastatic castration-resistant prostate cancer (mCRPC).
BörsenkürzelEPIX
UnternehmenESSA Pharma Inc
CEODr. David Ross Parkinson, M.D.
Websitehttps://www.essapharma.com/
Verwandte Finanzinstrumente
0.00%
-3.01%
+0.42%
+0.45%
0.00%
+0.50%
+8.57%
+0.48%
0.00%
0.00%
+0.97%
+0.68%
0.00%
+9.08%
+0.44%
-1.39%
-0.09%
+0.86%
-0.29%
0.00%Beliebte Symbole
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
68657.870
-1312.260 (-1.88%)
282.580
+22.390 (+8.61%)
2037.700
-14.030 (-0.68%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
